Visalytics
Visalytics
approved EB-2 (NIW)

Research Assistant

Cardiovascular Disease · China · 2026-01-09

Processing Time
77 days
Decision Date
2026-01-09
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research investigating risk factors and biomarkers for cardiovascular disease and type 2 diabetes using real-world evidence and advanced statistical models. The work focuses on improving early detection, informing U.S. clinical guidelines, and supporting targeted treatment decisions for these costly healthcare burdens.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor aims to strengthen how clinicians identify risk and intervene before complications occur in cardiovascular disease and diabetes, which are major U.S. healthcare burdens.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her M.P.H. degree and a documented trajectory of 6 peer-reviewed journal articles and 18 citations.

3 Balance of Interests Met

The case moved efficiently through adjudication as the record aligned around a practical, patient-impact endeavor that benefits the U.S. healthcare system.

Why This Petition Was Approved

The petition was approved based on the petitioner's Master of Public Health (M.P.H.) degree and a research record including 6 peer-reviewed journal articles, 1 first-authored conference article, and 18 citations. The case also highlighted her peer-review activity and the practical, patient-impact nature of her endeavor, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Healthcare · Iran

WeGreened EB-2 (NIW) approved
USA 141 days 2025-04-03
The petitioner proposes to investigate the molecular mechanisms underlying cardiovascular diseases to translate these insights into new pharmaceutical therapies. The work involves conducting research within U.S. academic environments to develop treatment paths that minimize invasive procedures and improve cardiovascular outcomes.
View Case

Researcher

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
126 days 2022-03-29
The petitioner proposes to continue her research on cardiovascular disease to facilitate the development of novel treatments and improve existing therapeutic approaches. Her work specifically focuses on elucidating the pathophysiology of cardiovascular diseases to advance next-generation medical interventions.
View Case

Research Scientist

Healthcare · India

WeGreened EB-2 (NIW) approved
New York 52 days 2025-03-10
The petitioner proposes to continue research on developing and implementing state-of-the-art digital health platforms for managing and preventing cardiovascular diseases in adults. She will utilize qualitative and mixed-method public health research approaches to design, administer, and analyze randomized control trials aimed at reducing the burden of cardiovascular diseases on vulnerable populations.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
New Jersey 6 days 2024-10-10
The petitioner proposes to develop advanced statistical models using real-world evidence and omics data to identify novel biomarkers for diseases. This work aims to facilitate the development of precision drug therapies and enhance the understanding of cancer, metabolic disorders, and cardiovascular diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2026-01-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 77 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist